Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

1.6K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.6K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

1.2K
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

598
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

686
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

943
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
943

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-medal arrays of Ta-doped rutile titania.

Journal of the American Chemical Society·2009
Same author

Modeling and optimization of microbial hyaluronic acid production by Streptococcus zooepidemicus using radial basis function neural network coupling quantum-behaved particle swarm optimization algorithm.

Biotechnology progress·2009
Same author

A facile approach for cupric ion detection in aqueous media using polyethyleneimine/PMMA core-shell fluorescent nanoparticles.

Nanotechnology·2009
Same author

[Overproduction of catalase by oxidative stress on Bacillus subtilis WSHDZ-01].

Sheng wu gong cheng xue bao = Chinese journal of biotechnology·2009
Same author

[Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma].

Zhonghua yi xue za zhi·2009
Same author

A monolithic polymeric microdevice for pH-responsive drug delivery.

Biomedical microdevices·2009
Same journal

[Multidisciplinary expert consensus on the prevention and treatment of gastrointestinal mucosal injury induced by antiplatelet drugs].

Zhonghua xin xue guan bing za zhi·2026
Same journal

[<i>Practical Cardiology</i>: the driving force behind my academic journey].

Zhonghua xin xue guan bing za zhi·2026
Same journal

[The role and mechanism of transient receptor potential M2 channel-mediated calcium homeostasis imbalance in the development of diabetic cardiomyopathy].

Zhonghua xin xue guan bing za zhi·2026
Same journal

[Advances of 18 kDa translocator protein (TSPO) in cardiovascular diseases: molecular imaging diagnosis and targeted therapy perspectives].

Zhonghua xin xue guan bing za zhi·2026
Same journal

[New progress in diagnosis and treatment of hypertrophic cardiomyopathy with left ventricular apical aneurysm].

Zhonghua xin xue guan bing za zhi·2026
Same journal

[Research progress of wearable devices in cardiovascular disease management].

Zhonghua xin xue guan bing za zhi·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

Chronic Ovine Model of Right Ventricular Failure and Functional Tricuspid Regurgitation
08:43

Chronic Ovine Model of Right Ventricular Failure and Functional Tricuspid Regurgitation

Published on: March 17, 2023

1.3K

[Recent progress on tricuspid regurgitation]

Mei-hua Wu, Jian Chen, Ping Gu

    Zhonghua Xin Xue Guan Bing Za Zhi
    |December 17, 2013
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
    08:31

    A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

    Published on: October 16, 2021

    3.7K
    Author Spotlight: Investigating the Underlying Mechanisms of Right Ventricular Failure in Pulmonary Hypertension
    04:49

    Author Spotlight: Investigating the Underlying Mechanisms of Right Ventricular Failure in Pulmonary Hypertension

    Published on: June 14, 2024

    1.4K

    Related Experiment Videos

    Last Updated: May 4, 2026

    Chronic Ovine Model of Right Ventricular Failure and Functional Tricuspid Regurgitation
    08:43

    Chronic Ovine Model of Right Ventricular Failure and Functional Tricuspid Regurgitation

    Published on: March 17, 2023

    1.3K
    A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
    08:31

    A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

    Published on: October 16, 2021

    3.7K
    Author Spotlight: Investigating the Underlying Mechanisms of Right Ventricular Failure in Pulmonary Hypertension
    04:49

    Author Spotlight: Investigating the Underlying Mechanisms of Right Ventricular Failure in Pulmonary Hypertension

    Published on: June 14, 2024

    1.4K